This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Analysis of effectiveness
The analysis of effectiveness was based on intention to treat.
The primary health outcomes assessed in the effectiveness analysis were: length of hospital stay and the reduction in the length of stay for women undertaking SF-ND in comparison with those in the WD group; the number (and percentage) of women with wound infection; the number (and percentage) of women with seroma formation; the volume in ml of seroma fluid aspirated; the change in degrees in shoulder abduction with regard to the baseline value, and the mean overall difference in shoulder abduction; psychological morbidity, measured as the number of patients with significant distress after operation, at 3 months, at 6 months and at 12 months.
Patients undergoing SF-ND were discharged after 48 hours if they were fully mobile, able to perform common activities of daily living, able to tolerate a full diet, required only analgesia and reported to be able to manage at home. WD patients were discharged home on drain removal. Shoulder abduction was measured by means of a goniometer. Distress was measured by means of the General Health Questionnaire (GHQ-28), considering as the initial cut-off point the one indicating significant distress. It was stated that the GHQ-28, the Mental Adjustment to Cancer (MAC) scale, the Illness Perception Questionnaire (IPQ) and the Eysenck Personality Scales (EPS), were given to the patients at the first post-operative visit, and at 3, 6 and 12 months in order to evaluate psychological morbidity of the patients. However, results were only reported for the GHQ-28 and the EPS. The authors' justification to exclude the other outcomes was that there was no evidence of difference between WD and SF-ND patients. The authors reported that the groups were comparable at analysis in terms of age, EPS and shoulder movement, although they did not report any statistical test to show that the differences were non-significant.
Effectiveness results
The results for women undergoing mastectomy were as follows (standard deviations in brackets):
The length of hospital stay was 5.59 days (SD 1.05) for WD patients, and 4.18 days (SD 1.51) for SF-ND patients.
There was a reduction in the length of stay for women undertaking SF-ND in comparison with those in the WD group of 1.41 days (95% CI: 1.04 -1.78; p<0.001).
The number (and percentage) of women with wound infection was 10 (10%) in the WD group, and 10 (11%) among the SF-ND patients.
In the WD group, 52 patients had seroma formation (55%), and in the SF-ND group, 57 (61%) patients had seroma formation.
The volume of seroma fluid aspirated (standard errors in brackets) was 213 ml (41) for WD patients, and 184 ml (28) for SF-ND patients.
The change in the shoulder abduction with regard to the baseline value (standard errors in brackets) was -27.9 degrees (2.6) for WD patients versus -29.3 degrees (2.1) for SF-ND patients after the operation; -6.9 degrees (2.0) for WD patients versus -9.6 degrees (2.3) for SF-ND patients at 3 months; -2.8 degrees (1.9) for WD patients versus -8.8 degrees (2.1) for SF-ND patients at 6 months; and -0.1 degrees (2.3) for WD patients versus -3.2 degrees (2.4) for SF-ND patients at 12 months. The mean overall difference in shoulder abduction in favour of the WD patients was 2.4 degrees (95% CI: -0.8 -6.1; p=0.13).
The numbers of patients presenting significant distress were:
for WD patients -after operation 31 (38%); at 3 months 27 (39%); at 6 months 18 (25%); and at 12 months 12 (17%); and for SF-ND patients -after operation 30 (39%); at 3 months 30 (42%), at 6 months 21 (33%); and at 12 months 20 (30%).
The results for women undergoing breast-conserving surgery were (standard deviations are given in brackets):
The length of hospital stay was 4.86 days (SD 1.16) for WD patients, and 3.31 days (SD 0.96) for SF-ND patients. There was a reduction in the length of stay for women undertaking SF-ND of 1.55 days (95% CI: 1.24 -1.86; p<0.001) in comparison with those in the WD group.
The number (and percentage) of women with wound infection was 9 (10%) in the WD group, and 16 (18%) among the SF-ND patients.
In the WD group, 46 patients had seroma formation (51%), and in the SF-ND group, 41 (47%) patients had seroma formation.
The volume of seroma fluid aspirated (standard errors in brackets) was 122 ml (24) for WD patients, and 166 ml (19) for SF-ND patients.
The change in the shoulder abduction with regard to the baseline value (standard errors in brackets) was -23.0 degrees (2.0) for WD patients versus -24.4 degrees (2.3) for SF-ND patients after the operation; -10.7 degrees (1.9) for WD patients versus -6.4 degrees (2.3) for SF-ND patients at 3 months; -5.5 degrees (1.5) for WD patients versus -3.8 degrees (2.0) for SF-ND patients at 6 months; and -2.2 degrees (1.8) for WD patients versus -0.3 degrees (1.7) for SF-ND patients at 12 months. The difference in the mean overall shoulder abduction in favour of the WD patients was 0.7 degrees (95% CI: -2.1 -3.6; p=0.61).
The numbers (and percentages) of patients with significant distress were:
in the WD group -after operation 34 (43%); at 3 months 27 (40%); at 6 months 21 (31%); and at 12 months 15 (22%); and in the SF-ND group -after operation 30 (38%); at 3 months 29 (39%); at 6 months 15 (22%); and at 12 months 11 (16%).
Clinical conclusions
There was a significant reduction in the length of hospital stay for patients undergoing SF-ND in both parallel trials (mastectomy and breast-conserving surgery groups). Among the patients who underwent breast-conserving surgery, there was a higher percentage of patients in the WD group presenting significant distress in comparison with the SF-ND patients, although the difference was not shown to be statistically significant. After an initial deterioration in shoulder mobility after surgery, all patients returned to near-normal shoulder mobility after 12 months, with no significant differences among the groups. Overall, the number of patients presenting significant distress in both groups (WD and SF-ND), and in both trials (mastectomy and breast-conserving surgery), decreased over time.
